Esperion Therapeutics Aktie
2,69
EUR
-0,04
EUR
-1,61
%
3,16
USD
+0,01
USD
+0,32
%
Esperion Therapeutics jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Esperion Therapeutics Aktie Analyse
| 29.09.15 | Esperion Therapeutics Sell | Chardan Capital Markets | |
| 31.08.15 | Esperion Therapeutics Sell | Chardan Capital Markets | |
| 07.08.15 | Esperion Therapeutics Sell | Chardan Capital Markets | |
| 31.07.15 | Esperion Therapeutics Sell | Chardan Capital Markets | |
| 27.07.15 | Esperion Therapeutics Sell | Chardan Capital Markets | |
| 08.07.15 | Esperion Therapeutics Sell | Chardan Capital Markets | |
| 10.06.15 | Esperion Therapeutics Sell | Chardan Capital Markets | |
| 22.05.15 | Esperion Therapeutics Sell | Chardan Capital Markets | |
|
Werbung
|
|||
Werbung
Werbung